微门户首页  新闻  讨论区  活动  博客  求职招聘  行业报告  圈内成员  供应   
已读[59] 发布: 2013/08/18 16:46:36
Healio Researchers concluded aspirin is a cost-effective prophylactic measure for patients who do not have a history of venous thromboembolism undergoing total joint arthroplasty compared to low-molecular-weight heparin , although patient age may factor into  ...
已读[49] 发布: 2013/08/18 16:46:31
Family Practice News Digital Network LONDON – Low-molecular-weight heparin therapy reduced the risk for recurrent implantation failure, improved pregnancy rates, and increased the number of live births in women who had failed prior fertility treatment in a 126-patient pilot study. As ... and more »
已读[85] 发布: 2013/08/17 16:54:52
海普瑞招股书曾披露,多普乐实业和天道医药未来生产低分子肝素钠原料药和低分子肝素制剂所需的肝素钠原料药将从海普瑞采购,预计未来多普乐实业和天道医药达产后所需的...
已读[93] 发布: 2013/08/17 16:52:55
2、肝素钠粗品原料采购价格上涨 公司表示,业绩下降的主要原因是“肝素钠原料药销售价格略有下降且肝素钠粗品原料采购价格上涨带来营业成本的上升,导致毛利率较去年...
已读[60] 发布: 2013/08/17 16:50:53
Healio Researchers concluded aspirin is a cost-effective prophylactic measure for patients who do not have a history of venous thromboembolism undergoing total joint arthroplasty compared to low-molecular-weight heparin , although patient age may factor into  ...
已读[64] 发布: 2013/08/17 16:50:49
Family Practice News Digital Network LONDON – Low-molecular-weight heparin therapy reduced the risk for recurrent implantation failure, improved pregnancy rates, and increased the number of live births in women who had failed prior fertility treatment in a 126-patient pilot study. As ... and more »
已读[100] 发布: 2013/08/16 16:59:02
3、多普乐及天道医药从事的主要业务为低分子肝素制剂的研究、生产及销售, 与公司从事的肝素钠原料药在主要适应症、产业链位置及客户等方面均不相同,多 普乐、...
已读[92] 发布: 2013/08/16 16:57:48
【提问】老师好:围手术期间,一般是手术前一周停用抗血小板,抗凝制剂,改用作用时间短的 低分子肝素,或普通肝素,那么我想问,手术当天是否停用任何抗凝抗血小板制剂呢...
已读[84] 发布: 2013/08/16 16:57:22
天马精化(甲方)于2013年8月12日与苏州鸿洋医药科技有限公司(乙方)签订《技术服务合同》,公司委托鸿洋医药就公司向国家食品药品监督管理局申报磺达肝癸钠、依诺...
已读[79] 发布: 2013/08/16 16:56:22
还原性谷胱甘肽,腺苷蛋氨酸,依诺肝素钠都处于生产审批阶段。长效力生素和泰思胶囊(治疗脑痴呆)进入三期临床。818不孕不育药在申请二期临床。阿米德韦和治疗性乙肝疫苗...
« 上一页  |   查看结果2521-2530共2625   |  下一页 »



最新报告


求职招聘